Dr. Manasi Shah

Introduction

Experience

• Attending Physician – Department of Medical Oncology and Hematology, University of Connecticut, USA (2012)
• Attending Physician- Department of Medical Oncology and Hematology, NewYork-Presbyterian Medical Group Westchester, NY, USA (2013-2015)
• Consultant, Medical Oncologist- Department of Medical Oncology, HCG Cancer Center, Ahmedabad (2015- current)

Expertise

• Dr. Manasi Shah has more than 10 years of experience in diagnosis and treating patients with cancer. She has an expertise in treating patients with solid tumors, especially Breast and Gynecological malignancies (including ovarian, uterine, and cervical cancers).
• She has been a part of several national and international trials for breast cancer with the aim of improving standard of care for cancer patients in India and to improve access to newer drugs to our patients.

Training and Certifications

• She is an American Board Certified Medical Oncologist and Haematologist.

Recognition

• Dr. Manasi Shah is board certified by the American Board of Medicine in Medical Oncology and Hematology and is a part of national and international oncology societies.

Publications

• Shah M, Saif MW, Pancreatic Cancer and Thrombosis: Highlights from the “2010 ASCO Annual Meeting”. J Pancreas (Online) 2010 Jul YY; 11(4):331-333
• Saif MW, Shah M., K-ras mutations in colorectal cancer: a practice changing discovery, Clin Adv Hematol Oncol. 2009 Jan;7(1):45-64.
• Saif MW, Shah M, Shah A, Fluoropyrimidine associated cardiotoxicity: revisited, Expert Opinion in Drug Safety, 2009 March: 8 (2): 191-202.
• Shah M, Summerhill E, Manthous CA, Medical Professionalism in the New Millennium: Are there intercultural differences?, Conn Med. 2009 May;73(5):289-94.
• Shah M, Agarwal B, Recent advances in management of acute myeloid leukemia (AML), Indian J Pediatr. 2008 Aug;75(8):831-7.

Presentations

• Lindner R, Offor O, Chaves J, Fischbach N, Shah M, Activation of the Insulin-LikeGrowth Factor Pathway distinguishes African American from European American
• patients with triple-negative breast cancer by Gene Expression Profiling, Annual San Antonio Breast cancer Symposium, December 2009
• Shah M, Fischbach N, Outcomes of triple negative breast cancer in African-Americans vs. Caucasians: a community based study, Annual San Antonio Breast Cancer Symposium, December 2008.

Other Doctors